A novel heterozygous variant in FGF9 associated with previously unreported features of multiple synostosis syndrome 3
Open Access
- 11 November 2020
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 99 (2) , 325-329
Abstract
Human multiple synostoses syndrome 3 is an autosomal dominant disorder caused by pathogenic variants in FGF9. Only two variants have been described in FGF9 in humans so far, and one in mice. Here we report a novel missense variant c.566C > G, p.(Pro189Arg) in FGF9. Functional studies showed this variant impairs FGF9 homodimerization, but not FGFR3c binding. We also review the findings of cases reported previously and report on additional features not described previously.Keywords
Funding Information
- National Health and Medical Research Council (441102)
This publication has 8 references indexed in Scilit:
- Ovotesticular disorders of sex development in FGF9 mouse models of human synostosis syndromesHuman Molecular Genetics, 2020
- Regulation of Receptor Binding Specificity of FGF9 by an Autoinhibitory HomodimerizationStructure, 2017
- FGF9 mutation causes craniosynostosis along with multiple synostosesHuman Mutation, 2017
- A point mutation in Fgf9 impedes joint interzone formation leading to multiple synostoses syndromeHuman Molecular Genetics, 2017
- Homodimerization Controls the Fibroblast Growth Factor 9 Subfamily's Receptor Binding and Heparan Sulfate-Dependent Diffusion in the Extracellular MatrixMolecular and Cellular Biology, 2009
- Multiple Synostoses Syndrome Is Due to a Missense Mutation in Exon 2 of FGF9 GeneThe American Journal of Human Genetics, 2009
- FGF9 monomer–dimer equilibrium regulates extracellular matrix affinity and tissue diffusionNature Genetics, 2009
- Crystal Structure of Fibroblast Growth Factor 9 Reveals Regions Implicated in Dimerization and AutoinhibitionJournal of Biological Chemistry, 2001